Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...
Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...
Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...
There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.
Myocardial perfusion imaging has limited sensitivity for the detection of high-risk coronary artery disease (CAD). We tested the hypothesis that a normal coronary flow reserve (CFR) would be helpful ...
See an invited perspective on this article on page 1412. Tumor growth and spread are determined not only by cancer cells but also by the nonmalignant constituents of the malignant lesion, which are ...
Journal of Nuclear Medicine December 2025, jnumed.125.270770; DOI: https://doi.org/10.2967/jnumed.125.270770 ...
Auger electron (AE) radiopharmaceutical therapy (RPT) may have the same therapeutic efficacy as α-particles for oncologic small disease, with lower risks of normal-tissue toxicity. The seeds of using ...
Selective internal radiotherapy (SIRT), also termed radioembolization using 90 Y-loaded microspheres, is an increasingly performed treatment for patients with unresectable primary tumors and ...
Journal of Nuclear Medicine January 2026, jnumed.125.270906; DOI: https://doi.org/10.2967/jnumed.125.270906 ...
Journal of Nuclear Medicine January 2026, jnumed.125.270946; DOI: https://doi.org/10.2967/jnumed.125.270946 ...
The LFER 150 PET/CT device (large–field-of-view extreme-resolution portable research imager) is a system for nonhuman primate (NHP) imaging. The objective of this study was to evaluate the performance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback